AHCO
AdaptHealth Corp.NASDAQHealthcare$12.03+1.43%ClosedMarket Cap: $1.64B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.08
P/S
0.58
EV/EBITDA
7.10
DCF Value
$31.46
FCF Yield
13.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
6.5%
Operating Margin
7.8%
Net Margin
-2.6%
ROE
-4.6%
ROA
-1.7%
ROIC
6.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $846.3M | 19.2% | $54.3M | $-102.8M | $-0.73 | — |
| FY 2025 | $3.24B | 17.5% | $186.3M | $-70.8M | $-0.52 | — |
| Q3 2025 | $820.3M | 18.5% | $65.9M | $22.5M | $0.16 | — |
| Q2 2025 | $591.8M | -9.1% | $79.3M | $14.7M | $0.10 | — |
| Q1 2025 | $580.5M | -13.3% | $23.2M | $-7.2M | $-0.05 | — |
| Q4 2024 | $856.6M | 38.3% | $97.7M | $50.3M | $0.34 | — |
| FY 2024 | $3.26B | 20.9% | $263.7M | $90.4M | $0.61 | — |
| Q3 2024 | $597.5M | -14.1% | $63.5M | $22.9M | $0.15 | — |
| Q2 2024 | $595.0M | -7.0% | $52.0M | $19.4M | $0.13 | — |
| Q1 2024 | $594.1M | -6.9% | $50.5M | $-2.1M | $-0.02 | — |
| Q4 2023 | $1.48B | 52.7% | $-217.8M | $-254.5M | $-1.91 | — |
| FY 2023 | $3.20B | 21.3% | $-598.4M | $-678.9M | $-5.31 | — |